Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction

J Microbiol Biotechnol. 2022 Jul 28;32(7):825-834. doi: 10.4014/jmb.2203.03022. Epub 2022 Jun 30.

Abstract

Inflammatory bowel disease (IBD) is a global disease that is in increasing incidence. The gut, which contains the largest amount of lymphoid tissue in the human body, as well as a wide range of nervous system components, is integral in ensuring intestinal homeostasis and function. By interacting with gut microbiota, immune cells, and the enteric nervous system, the intestinal barrier, which is a solid barrier, protects the intestinal tract from the external environment, thereby maintaining homeostasis throughout the body. Destruction of the intestinal barrier is referred to as developing a "leaky gut," which causes a series of changes relating to the occurrence of IBD. Changes in the interactions between the intestinal barrier and gut microbiota are particularly crucial in the development of IBD. Exploring the leaky gut and its interaction with the gut microbiota, immune cells, and the neuroimmune system may help further explain the pathogenesis of IBD and provide potential therapeutic methods for future use.

Keywords: Inflammatory bowel disease; gut microbiota; intestinal barrier; neuroimmune system.

Publication types

  • Review

MeSH terms

  • Gastrointestinal Microbiome* / physiology
  • Homeostasis
  • Humans
  • Inflammatory Bowel Diseases*